PACIRA BIOSCIENCES, INC. Number of Reportable Segments
PACIRA BIOSCIENCES, INC. (PCRX) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. number of reportable segments for fiscal 2012 was 1.00 item.
item
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2012-12-31 | 1.00 item 10-K · filed 2013-03-07 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-07-30 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-29 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-02 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-03 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-28 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-03 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-04 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-28 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-03 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-03-01 | |||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-10-30 | |||
| 2020-06-30 | 1.00 segment 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | 1.00 segment 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-02-21 | |||
| 2019-09-30 | 1.00 segment 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | 1.00 segment 10-Q · filed 2019-08-08 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-02-28 | |||
| 2017-12-31 | 1.00 segment 10-K · filed 2018-02-28 | |||
| 2016-12-31 | 1.00 segment 10-K · filed 2017-03-01 | |||
| 2015-12-31 | 1.00 segment 10-K · filed 2016-02-25 | |||
| 2014-12-31 | 1.00 segment 10-K · filed 2015-02-24 | |||
| 2013-12-31 | 1.00 segment 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |